You are being forwarded to your requested URL of https://www.finnegan.com/en/insights/blogs/at-the-ptab-blog/ptab-invalidates-united-therapeutics-patent-relating-to-the-hypertension-drug-tyvasor.html?utm_source=mondaq&utm_medium=syndication&utm_content=sourceoriginal&utm_campaign=